Disease & disorder

high-grade neuroendocrine carcinoma of the corpus uteri

MONDO:0016269

High-grade neuroendocrine carcinoma of the corpus uteri is an extremely rare, aggressive, primary uterine neoplasm, originating from neuroendocrine cells scattered within the endometrium, characterized, macroscopically, by a bulky, frequently polypoid, mass with abundant necrosis located in the uterus and, histologically, by rosette-like and cord-like structures consisting of small, rounded cells with oval nuclei and scarce cytoplasm. Patients often present with dysfunctional uterine bleeding, pelvic or abdominal mass and, especially in later stages of the disease, abdominal pain. Symptomatic metastatic spread or symptoms related to a paraneoplastic syndrome, such as retinopathy, or Cushing syndrome due to ectopic ACTH production, may be associated.

Outbreak surveillance

Global reported events

Explore recent public health notices potentially related to high-grade neuroendocrine carcinoma of the corpus uteri. Results are keyword matches, not yet verified disease-to-outbreak relationships.

View high-grade neuroendocrine carcinoma of the corpus uteri on the outbreak map →
Clinical trials0
Recruiting0
Drug concepts studied0
Synonyms3
Advertisement
Background context

high-grade neuroendocrine carcinoma of the corpus uteri

Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Drugs being studied

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.